# The Wistar Institute : A Global Leader in Biomedical Research

> The Wistar Institute, a global leader in biomedical research, specializes in cancer, immunology, infectious disease \& vaccine development\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Home](https://www.wistar.org/)
- [Vaccine \& Immunotherapy Center](https://www.wistar.org/vaccine-immunotherapy-center/)
- [HIV Cure and Viral Diseases Center](https://www.wistar.org/hiv-cure-and-viral-diseases-center/)
- [Ellen and Ronald Caplan Cancer Center of The Wistar Institute](https://www.wistar.org/cancer/ellen-and-ronald-caplan-cancer-center/)
- [About Wistar](https://www.wistar.org/about-wistar/)

## Posts
- [Creating a Culture that Allows Science to Thrive](https://www.wistar.org/featured-news/creating-a-culture-that-allows-science-to-thrive/): In this edition of People Behind the Science, we speak with Jo\-Ann Mendel, VP of Human Resources, to learn how HR supports Wistar Science\.
- [New Apprenticeship Cohort Helps Life Science Employers Build Skilled Talent Pipeline](https://www.wistar.org/press-releases/new-apprenticeship-cohort-helps-life-science-employers-build-skilled-talent-pipeline/): Joint Program between The Wistar Institute and Apprenti expands access to workforce development opportunities in Central New Jersey
- [Jianliang Xu, Ph\.D\.](https://www.wistar.org/our-scientists/jianliang-xu/): \<ul\>\<li\>Assistant Professor, HIV Cure and Viral Diseases Center\</li\>\</ul\>
- [The Wistar Institute Recruits Torben Schiffner, Ph\.D\., to Advance Next\-Generation Immune Therapies](https://www.wistar.org/press-releases/the-wistar-institute-recruits-torben-schiffner-ph-d-to-advance-next-generation-immune-therapies/): Schiffner merges biology, AI and reverse vaccinology to target HIV \& emerging pandemic threats

- [Wistar Scientists Develop Single\-Dose DNA Method for Delivering Long\-acting Weight Loss and Diabetes Drugs](https://www.wistar.org/press-releases/wistar-scientists-develop-single-dose-dna-method-for-delivering-long-acting-weight-loss-and-diabetes-drugs/): While still preclinical, the study supports DNA delivery as a promising strategy for long\-acting biologic therapies\.

## Categories
- [Featured News](https://www.wistar.org/articles/featured-news/)
- [Press Releases](https://www.wistar.org/articles/press-releases/)
- [Our Scientists](https://www.wistar.org/articles/our-scientists/)
- [Blog](https://www.wistar.org/articles/blog/)
- [Vaccine \& Immunotherapy Center](https://www.wistar.org/articles/vaccine-immunotherapy-center/)

## Optional
- [Sitemap index](https://www.wistar.org/sitemap_index.xml)